Pages that link to "Q38241714"

The following pages link to Therapeutic uses of anti-interleukin-6 receptor antibody (Q38241714):

Displaying 40 items.

• Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs (Q26800158) (← links)
• Beneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive Setup (Q27315053) (← links)
• CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia (Q28084879) (← links)
• Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation (Q35439628) (← links)
• Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys (Q36579912) (← links)
• Probing binding mechanism of interleukin-6 and olokizumab: in silico design of potential lead antibodies for autoimmune and inflammatory diseases (Q38382090) (← links)
• Developments in therapy with monoclonal antibodies and related proteins. (Q38750042) (← links)
• Use of polyclonal/monoclonal antibody therapies in transplantation (Q38769922) (← links)
• Ligand-inducible dimeric antibody for selecting antibodies against a membrane protein based on mammalian cell proliferation. (Q38826849) (← links)
• Unintended Immunological Consequences of Biologic Therapy. (Q38871098) (← links)
• Immunotherapeutic implications of IL-6 blockade for cytokine storm. (Q38887311) (← links)
• Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery (Q38958166) (← links)
• Immunopathology alters Th17 cell glucocorticoid sensitivity (Q38959155) (← links)
• Pharmacological and immunological targeting of tumor mesenchymalization (Q39029043) (← links)
• Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature (Q39445471) (← links)
• IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections. (Q39815392) (← links)
• Regulation of IL-6 in Immunity and Diseases. (Q40508670) (← links)
• Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells (Q42013055) (← links)
• Puerarin Exerts an Antiinflammatory Effect by Inhibiting NF-kB and MAPK Activation in Staphylococcus aureus-Induced Mastitis (Q44123813) (← links)
• Pattern Recognition of the Multiple Sclerosis Syndrome (Q47096340) (← links)
• Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome (Q47909467) (← links)
• Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis (Q48022107) (← links)
• Treatment strategies for autoimmune encephalitis (Q49213573) (← links)
• Interleukin 6 and complement serum level study in Parkinson's disease (Q50051512) (← links)
• Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review (Q50089138) (← links)
• Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction. (Q50137412) (← links)
• Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial (Q50700806) (← links)
• Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients. (Q53504304) (← links)
• The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration. (Q55246388) (← links)
• MC1R gene polymorphisms are associated with dysfunctional immune responses and wound infection after burn injury (Q57024572) (← links)
• Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy (Q57116991) (← links)
• Investigations of cellular immunity in juvenile idiopathic arthritis (Q64112732) (← links)
• Interleukin-6: designing specific therapeutics for a complex cytokine (Q88562718) (← links)
• Interleukin-6 inhibition in the management of non-infectious uveitis and beyond (Q90117830) (← links)
• Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation (Q90312369) (← links)
• Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis (Q92347427) (← links)
• KIT D816V and the cytokine storm in mastocytosis: production and role of interleukin-6 (Q92365302) (← links)
• The Effect of lnterleukin-6 Gene Polymorphism on Pediatric Pneumonia (Q92862866) (← links)
• Transcriptomic Analysis of Chicken Lungs Infected With Avian and Bovine Pasteurella multocida Serotype A (Q98771941) (← links)
• Experimental induction of blunt chest trauma in mice: A modified approach with evaluation in dummies and cadavers (Q99579007) (← links)